TREA

87875063 - CRINETICS

Follow

Information

  • Trademark
  • 87875063
  • Serial Number
    87875063
  • Filing Date
    April 12, 2018
    6 years ago
  • Transaction Date
    February 05, 2024
    11 months ago
  • Status Date
    July 19, 2022
    2 years ago
  • Published for Opposition Date
    September 04, 2018
    6 years ago
  • Location Date
    July 19, 2022
    2 years ago
  • First Use Anywhere Date
    May 12, 2021
    3 years ago
  • First Use In Commerce Date
    May 12, 2021
    3 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    KEELEY, ALISON REBECCA
  • Attorney Docket Number
    48369-TM1001
    Attorney Name
    Chelsea E. Carbone
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CRINETICS
Case File Statements
  • GS0051: Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to treat or prevent dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to target neuropeptide receptors; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain
  • GS0421: Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others
Case File Event Statements
  • 7/19/2022 - 2 years ago
    39 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 7/19/2022 - 2 years ago
    38 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 1/5/2022 - 3 years ago
    37 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/5/2022 - 3 years ago
    36 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/5/2022 - 3 years ago
    35 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT
  • 11/30/2021 - 3 years ago
    34 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 10/29/2021 - 3 years ago
    33 - USE AMENDMENT FILED Type: IUAF
  • 10/29/2021 - 3 years ago
    32 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 5/8/2021 - 3 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/7/2021 - 3 years ago
    30 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 4/29/2021 - 3 years ago
    29 - SOU EXTENSION 5 FILED Type: EXT5
  • 5/7/2021 - 3 years ago
    28 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 4/29/2021 - 3 years ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/30/2020 - 4 years ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/28/2020 - 4 years ago
    25 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 10/28/2020 - 4 years ago
    24 - SOU EXTENSION 4 FILED Type: EXT4
  • 10/28/2020 - 4 years ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/28/2020 - 4 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/24/2020 - 4 years ago
    21 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 4/24/2020 - 4 years ago
    20 - SOU EXTENSION 3 FILED Type: EXT3
  • 4/24/2020 - 4 years ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/23/2019 - 5 years ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/21/2019 - 5 years ago
    17 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/21/2019 - 5 years ago
    16 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/21/2019 - 5 years ago
    15 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/19/2019 - 5 years ago
    14 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/17/2019 - 5 years ago
    13 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 4/17/2019 - 5 years ago
    12 - SOU EXTENSION 1 FILED Type: EXT1
  • 4/17/2019 - 5 years ago
    11 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/17/2019 - 5 years ago
    10 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/17/2019 - 5 years ago
    9 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/30/2018 - 6 years ago
    8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/4/2018 - 6 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/4/2018 - 6 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/15/2018 - 6 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/1/2018 - 6 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/31/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/21/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/16/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP